vTv Therapeutics (VTVT) Net Margin Growth (3y) (2017 - 2024)

vTv Therapeutics (VTVT) Net Margin Growth (3y) (2017 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 9,283.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -569.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 6,537.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 vTv Therapeutics 19.21 Mn 19.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 5.70 Mn
Mar 31, 2024 11,553.00
Dec 31, 2022 4.56 Mn
Jun 30, 2022 -3.47 Mn
Mar 31, 2022 8,201.00
Dec 31, 2021 -7.83 Mn
Sep 30, 2021 2,187.00
Jun 30, 2021 -636,752.00
Mar 31, 2021 -11,947.00
Dec 31, 2020 596,803.00
Sep 30, 2020 5.02 Mn
Mar 31, 2020 -4.19 Mn
Dec 31, 2019 -11.32 Mn
Sep 30, 2019 -3.90 Mn
Jun 30, 2019 775,156.00
Mar 31, 2019 316,339.00
Dec 31, 2018 -152,405.00
Sep 30, 2018 732,686.00
Jun 30, 2018 907,742.00
Mar 31, 2018 1.91 Mn